Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease : The Bypass Angioplasty Revascularization Investigation (BARI)

In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. From the Bypass Angioplasty Revascularization Invest...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 100; no. 9; pp. 910 - 917
Main Authors KIP, K. E, BOURASSA, M. G, DIMAS, A. P, JONES, R. H, SOPKO, G, DETRE, K. M, JACOBS, A. K, SCHWARTZ, L, FEIT, F, ALDERMAN, E. L, WEINER, B. H, WEISS, M. B, KELLETT, M. A, SHARAF, B. L
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 31.08.1999
American Heart Association, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined.
AbstractList Background —In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. Methods and Results —From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR ( P <0.001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. Conclusions —Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined.
In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined.
BACKGROUNDIn PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain.METHODS AND RESULTSFrom the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG.CONCLUSIONSOverall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined.
BACKGROUND: In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion outcome. The unique contribution of these components on long-term patient outcome is uncertain. METHODS AND RESULTS: From the Bypass Angioplasty Revascularization Investigation (BARI), 2047 patients who underwent first-time PTCA were evaluated. Before enrollment, all significant lesions were assessed by the PTCA operator for clinical importance and intention to dilate. Complete revascularization (CR) was defined as successful dilatation of all clinically relevant lesions. Planned CR was indicated in 65% of all patients. More lesions were intended for PTCA in these patients compared with those with planned IR (2.8 versus 2.1). Successful dilatation of all intended lesions occurred in 45% of patients with planned CR versus 56% with planned IR (P<0. 001). In multivariable analysis, planned IR (versus planned CR), initial lesions attempted (not all versus all intended lesions attempted), and initial lesion outcome (not all versus all attempted lesions successful) were unrelated to 5-year risk of cardiac death or death/myocardial infarction but were all independently related to risk of CABG. CONCLUSIONS: Overall, a pre-PTCA strategy of IR in BARI-like patients appears comparable to a strategy of CR except for a higher need for CABG. Whether the use of new devices may attenuate the elevated risk of CABG in patients with multivessel disease and planned IR remains to be determined.
Author KIP, K. E
DETRE, K. M
BOURASSA, M. G
SHARAF, B. L
DIMAS, A. P
JACOBS, A. K
SOPKO, G
SCHWARTZ, L
ALDERMAN, E. L
KELLETT, M. A
FEIT, F
WEISS, M. B
JONES, R. H
WEINER, B. H
Author_xml – sequence: 1
  givenname: K. E
  surname: KIP
  fullname: KIP, K. E
  organization: Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa, United States
– sequence: 2
  givenname: M. G
  surname: BOURASSA
  fullname: BOURASSA, M. G
  organization: Montreal Heart Institute, Montreal, Canada
– sequence: 3
  givenname: A. P
  surname: DIMAS
  fullname: DIMAS, A. P
  organization: Cleveland, Clinic Foundation, Cleveland, Ohio, United States
– sequence: 4
  givenname: R. H
  surname: JONES
  fullname: JONES, R. H
  organization: Duke University Medical Center, Durham, NC, United States
– sequence: 5
  givenname: G
  surname: SOPKO
  fullname: SOPKO, G
  organization: National Heart, Lung, and Blood Institute, Bethesda, Md, United States
– sequence: 6
  givenname: K. M
  surname: DETRE
  fullname: DETRE, K. M
  organization: Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pa, United States
– sequence: 7
  givenname: A. K
  surname: JACOBS
  fullname: JACOBS, A. K
  organization: Boston Medical Center, Boston, Mass, Canada
– sequence: 8
  givenname: L
  surname: SCHWARTZ
  fullname: SCHWARTZ, L
  organization: Toronto Hospital, Toronto, Canada
– sequence: 9
  givenname: F
  surname: FEIT
  fullname: FEIT, F
  organization: New York University Medical Center, New York, NY, United States
– sequence: 10
  givenname: E. L
  surname: ALDERMAN
  fullname: ALDERMAN, E. L
  organization: Stanford University Medical Center, Palo Alto, Calif, United States
– sequence: 11
  givenname: B. H
  surname: WEINER
  fullname: WEINER, B. H
  organization: University of Massachusetts Medical Center, Worcester, Mass, United States
– sequence: 12
  givenname: M. B
  surname: WEISS
  fullname: WEISS, M. B
  organization: New York, Medical College, Valhalla, NY, United States
– sequence: 13
  givenname: M. A
  surname: KELLETT
  fullname: KELLETT, M. A
  organization: Maine Medical Center, Portland, Me, United States
– sequence: 14
  givenname: B. L
  surname: SHARAF
  fullname: SHARAF, B. L
  organization: Rhode Island Hospital, Providence, RI, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1916188$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10468520$$D View this record in MEDLINE/PubMed
BookMark eNpdkU9vEzEQxS1URNPCnROyEEJw2GVs719uaVRgpUqgKJwtxzubunK8i-0tCl-lXxaXRAJxst74N29G8y7ImRsdEvKSQc5YxT4Ay1fdOmcAeZu3DJ6QBSt5kRWlaM_IAgDarBacn5OLEO6SrERdPiPnDIqqKTksyEPnBjuj00jHgU4es2-b1ZKG6FXE3YEq11PjTDTK0j8_HsNsY6rRSUWDLgb608Rbuk9Vc48hoKW9CagC0o90c4v06jCpEOjS7cw4WRXiga7xXgU9W-XNr-QyOtq51BvN7qjeXS3X3fvn5OmgbMAXp_eSfP90vVl9yW6-fu5Wy5tMi6KMWdVvC2w5V7rvFa-4VhxhgJIL0XDGFVRDiQPTqLko-4EDL6Bui76ALbCGVeKSvD36Tn78Mac15N4EjdYqh-McZP14ON6IBL7-D7wbZ-_SbjINqgvGG5YgOELajyF4HOTkzV75g2QgH1OTwGRKLUmQrUyppZZXJ995u8f-n4ZjTAl4cwLS2ZQdvHLahL9cm2ybRvwGzX-hpQ
CODEN CIRCAZ
Cites_doi 10.1016/0002-8703(88)90511-X
10.1161/circ.71.4.3156011
10.1056/NEJM199607253350401
10.1016/S0002-9149(99)80389-0
10.1016/S0003-4975(97)00451-7
10.1016/0735-1097(88)90278-1
10.1161/circ.78.2.2969312
10.1016/0002-9149(87)90287-6
10.1016/0002-8703(90)90154-P
10.1161/circ.75.4.3103950
10.1016/0002-9149(92)91271-5
10.1016/S0002-9149(97)89173-4
10.1016/S0735-1097(85)80298-9
10.1111/j.2517-6161.1972.tb00899.x
10.1016/0735-1097(90)90342-M
10.1016/0735-1097(93)90532-6
10.1016/S0735-1097(84)80263-6
10.1016/S0002-9149(99)80390-7
10.1161/circ.77.3.2963707
10.1161/circ.96.7.2162
10.1016/0002-8703(94)90377-8
10.1016/0002-8703(92)90687-Q
ContentType Journal Article
Copyright 1999 INIST-CNRS
Copyright American Heart Association, Inc. Aug 31, 1999
Copyright_xml – notice: 1999 INIST-CNRS
– notice: Copyright American Heart Association, Inc. Aug 31, 1999
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
NAPCQ
U9A
7X8
DOI 10.1161/01.CIR.100.9.910
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Career and Technical Education (Alumni Edition)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 917
ExternalDocumentID 44541776
10_1161_01_CIR_100_9_910
10468520
1916188
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
08R
0R~
0ZK
18M
1CY
1J1
29B
2FS
2WC
354
40H
41~
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
8W4
AAAXR
AAEJM
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAPBV
AAQKA
AARTV
AASOK
AASXQ
AAWTL
AAXQO
AAYOK
ABASU
ABBUW
ABDIG
ABFLS
ABOCM
ABPMR
ABPTK
ABQRW
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACOAL
ACRKK
ACRZS
ACWDW
ACWRI
ACXNZ
ADBBV
ADCYY
ADFPA
ADGIM
ADNKB
AE3
AE6
AEBDS
AENEX
AFCHL
AFDTB
AFFNX
AFUWQ
AGINI
AHMBA
AHRYX
AHVBC
AIJEX
AJIOK
AJJEV
AJNYG
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
ASPBG
AVWKF
AWKKM
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BS7
BYPQX
C1A
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FEDTE
FL-
FW0
GQDEL
GX1
H0~
H13
HVGLF
HZ~
H~9
IKREB
IKYAY
IN~
IPNFZ
IQODW
J5H
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
M18
MVM
N4W
N9A
NEJ
N~7
N~B
N~M
O9-
OAG
OAH
OBH
OCB
OCUKA
ODA
ODMTH
OGEVE
OHH
OHT
OHYEH
OJAPA
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQEST
PQQKQ
R58
RAH
RHF
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WHG
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YQJ
YSK
YXB
YYM
YYP
YZZ
ZA5
ZFV
ZGI
ZXP
ZY1
ZZMQN
~H1
AAAAV
AAIQE
AAUEB
ABJNI
ACILI
ADGGA
ADHPY
AEETU
AFEXH
AHOMT
AHQNM
AINUH
AJNWD
AJZMW
AMNEI
CGR
CUY
CVF
ECM
EIF
FCALG
NPM
AAYXX
CITATION
K9.
NAPCQ
U9A
7X8
ID FETCH-LOGICAL-c345t-6db4e922acdda262ca2e0f052338212a06f5ef1cec235df20240794d40b018163
ISSN 0009-7322
IngestDate Fri Oct 25 23:11:29 EDT 2024
Thu Oct 10 19:14:21 EDT 2024
Fri Aug 23 01:07:26 EDT 2024
Wed Oct 16 00:50:48 EDT 2024
Fri Nov 25 06:01:32 EST 2022
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
Multiple
Prognosis
Coronary artery
Instrumentation therapy
Stenosis
Cardiovascular disease
Instrumental dilatation
Coronary heart disease
Artery
Arterial disease
Vascular disease
Treatment
Follow up study
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c345t-6db4e922acdda262ca2e0f052338212a06f5ef1cec235df20240794d40b018163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 10468520
PQID 212741281
PQPubID 24119
PageCount 8
ParticipantIDs proquest_miscellaneous_70006283
proquest_journals_212741281
crossref_primary_10_1161_01_CIR_100_9_910
pubmed_primary_10468520
pascalfrancis_primary_1916188
PublicationCentury 1900
PublicationDate 1999-08-31
PublicationDateYYYYMMDD 1999-08-31
PublicationDate_xml – month: 08
  year: 1999
  text: 1999-08-31
  day: 31
PublicationDecade 1990
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
– name: Baltimore
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 1999
Publisher Lippincott Williams & Wilkins
American Heart Association, Inc
Publisher_xml – name: Lippincott Williams & Wilkins
– name: American Heart Association, Inc
References (e_1_3_1_17_2) 1992; 3
e_1_3_1_21_2
(e_1_3_1_22_2) 1972; 34
e_1_3_1_23_2
e_1_3_1_8_2
e_1_3_1_13_2
(e_1_3_1_24_2) 1995; 75
e_1_3_1_7_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_9_2
e_1_3_1_10_2
e_1_3_1_20_2
e_1_3_1_4_2
e_1_3_1_3_2
e_1_3_1_16_2
e_1_3_1_6_2
e_1_3_1_15_2
e_1_3_1_5_2
e_1_3_1_14_2
e_1_3_1_2_2
e_1_3_1_19_2
e_1_3_1_1_2
e_1_3_1_18_2
References_xml – ident: e_1_3_1_5_2
  doi: 10.1016/0002-8703(88)90511-X
– ident: e_1_3_1_1_2
  doi: 10.1161/circ.71.4.3156011
– ident: e_1_3_1_15_2
  doi: 10.1056/NEJM199607253350401
– ident: e_1_3_1_16_2
  doi: 10.1016/S0002-9149(99)80389-0
– ident: e_1_3_1_12_2
  doi: 10.1016/S0003-4975(97)00451-7
– ident: e_1_3_1_6_2
  doi: 10.1016/0735-1097(88)90278-1
– ident: e_1_3_1_18_2
  doi: 10.1161/circ.78.2.2969312
– ident: e_1_3_1_3_2
  doi: 10.1016/0002-9149(87)90287-6
– ident: e_1_3_1_8_2
  doi: 10.1016/0002-8703(90)90154-P
– ident: e_1_3_1_19_2
  doi: 10.1161/circ.75.4.3103950
– ident: e_1_3_1_14_2
– ident: e_1_3_1_13_2
  doi: 10.1016/0002-9149(92)91271-5
– ident: e_1_3_1_20_2
  doi: 10.1016/S0002-9149(97)89173-4
– ident: e_1_3_1_2_2
  doi: 10.1016/S0735-1097(85)80298-9
– volume: 34
  start-page: 187
  year: 1972
  ident: e_1_3_1_22_2
  publication-title: J R Stat Soc (B)
  doi: 10.1111/j.2517-6161.1972.tb00899.x
– ident: e_1_3_1_7_2
  doi: 10.1016/0735-1097(90)90342-M
– ident: e_1_3_1_10_2
  doi: 10.1016/0735-1097(93)90532-6
– ident: e_1_3_1_23_2
  doi: 10.1016/S0735-1097(84)80263-6
– volume: 75
  start-page: 9C
  year: 1995
  ident: e_1_3_1_24_2
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(99)80390-7
– ident: e_1_3_1_4_2
  doi: 10.1161/circ.77.3.2963707
– ident: e_1_3_1_21_2
  doi: 10.1161/circ.96.7.2162
– ident: e_1_3_1_11_2
  doi: 10.1016/0002-8703(94)90377-8
– ident: e_1_3_1_9_2
  doi: 10.1016/0002-8703(92)90687-Q
– volume: 3
  start-page: 1189
  year: 1992
  ident: e_1_3_1_17_2
  publication-title: Coron Artery Dis
SSID ssj0006375
Score 1.7518996
Snippet In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial lesion...
Background —In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial...
BACKGROUND: In PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial...
BACKGROUNDIn PTCA patients with multivessel coronary artery disease, incomplete revascularization (IR) is the result of both pre-PTCA strategy and initial...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 910
SubjectTerms Aged
Angioplasty, Balloon, Coronary
Biological and medical sciences
Cardiology. Vascular system
Confounding Factors (Epidemiology)
Coronary Disease - pathology
Coronary Disease - therapy
Coronary heart disease
Disease-Free Survival
Female
Follow-Up Studies
Heart
Humans
Male
Medical sciences
Middle Aged
Multivariate Analysis
Severity of Illness Index
Treatment Outcome
Title Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease : The Bypass Angioplasty Revascularization Investigation (BARI)
URI https://www.ncbi.nlm.nih.gov/pubmed/10468520
https://www.proquest.com/docview/212741281
https://search.proquest.com/docview/70006283
Volume 100
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahgzEYY2t3ybpuehiDEezZsizbjyF0a9p1lC6Fwh6MLEs00DkhcTq6f7N_uqOLHbeksO7FJFasyD6fj879IPQ-znhchoH0QNYuPEoT7hWpJF6UCpWWqVKM6Wzk42_s4Iwensfnvd6fTtTSqi588XtjXsn_UBXOAV11luw9KNtOCifgM9AXjkBhOP4TjcdNhxETybaQ3slkNBy4grPXLtR3WmujuBk5lcvVpekJcGLLqero1_piYLJwr3QVcc0D1x6bpoLBdCFcl69NzXs6xoSj6dwm-1zBf-z7ra4PNwNCOnfJQWZBX9rRQ2DKhW2KfAlsa3DUjnwXF7_g58bG_VWCzmArAFgrha1skDbsveG8mZdENgfZl47ZEurR2BYzarlxEHRgl3V4a-biX6X7lmzeAVhoshr80fhUh4D4md9e2C22fWsTbEMTjVLEwjwIc5hBl3TOszzTSXwPCPAyEwkwPmo3exYlcdOsT99e4wln4afba7gh-Tye8yW8hMp2T7lbvTFizuQpeuL0Ezy0YHuGerLaRjvDitezn9f4AzYRw8YVs40eHrvAjB30o4UinincQBE3UMQAReygiM2IhSKeVriBItZQxB0oYgfF5-js8_5kdOC5vh2eiGhce6wsqMwI4aIsOWFEcCIDpf0PUQqSEg-YiqUKhRQkiktFdJk92BZKqo3yKSgIL9BWNavkK4R1C6UwETRQMKcgIU8TwrVJQfGIUZ710cfmmeZzW54lv4uCfbR346GvL8h014i0j3YbIuTuJV_mugEC1d7mPnrXjgIH1m41XsnZapkngUlEjvropaVcZyWUpTEJXt9jlbvo0fr9eYO26sVK7oHcWxdvDfL-Ak7UpO8
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+Pre-PTCA+Strategy+and+Initial+PTCA+Result+in+Patients+With+Multivessel+Disease&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Kip%2C+Kevin+E.&rft.au=Bourassa%2C+Martial+G.&rft.au=Jacobs%2C+Alice+K.&rft.au=Schwartz%2C+Leonard&rft.date=1999-08-31&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=100&rft.issue=9&rft.spage=910&rft.epage=917&rft_id=info:doi/10.1161%2F01.CIR.100.9.910&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_01_CIR_100_9_910
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon